MOLECULAR IN VITRO DIAGNOSIS OF BREAST CANCER
    1.
    发明申请
    MOLECULAR IN VITRO DIAGNOSIS OF BREAST CANCER 审中-公开
    分子乳腺癌的分子诊断

    公开(公告)号:US20120283132A1

    公开(公告)日:2012-11-08

    申请号:US13550872

    申请日:2012-07-17

    IPC分类号: C40B30/04

    摘要: A method for determining the benign or malignant state of a breast tumor in a biological sample is presented. The benign or malignant state is determined by measuring the variation of expression of twelve genes and at least one variant of each of the twelve genes when the variants exist, using a combination of 50 polynucleotide probe sets. An expression profile of the sample is then compared with reference expression profiles of control benign and malignant breast tissues. The probe sets can be arranged in a microarray.

    摘要翻译: 提出了一种用于确定生物样品中乳腺肿瘤的良性或恶性状态的方法。 通过使用50个多核苷酸探针组的组合,通过测量12种基因的表达变异和12种基因中的每一种的至少一种变体存在变体来确定良性或恶性状态。 然后将样品的表达谱与对照良性和恶性乳腺组织的参考表达谱进行比较。 探针组可以布置在微阵列中。